Period3 structural variation: A circadian biomarker associated with breast cancer in young women

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 1, 2005, Pages 268-270

  Zhu, Yong ^a   Brown, Heather N ^a   Zhang, Yawei ^a   Stevens, Richard G ^b   Zheng, Tongzhang ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PEPTIDES AND PROTEINS; PROTEIN PERIOD3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CIRCADIAN RHYTHM; CONTROLLED STUDY; DISEASE MARKER; EXON; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN STRUCTURE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; FEMALE; GENOTYPE; HUMANS; INTERVIEWS; LOGISTIC MODELS; MIDDLE AGED; NUCLEAR PROTEINS; RISK FACTORS; TRANSCRIPTION FACTORS; VARIATION (GENETICS);

EID: 12844282844     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Storch KF, Lipan O, Leykin I, et al. Extensive and divergent circadian gene expression in liver and heart. Nature 2002;417:78-83.
2. Fu L, Lee CC. The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer 2003;3:350-61.
3. Stevens RG, Rea MS. Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Controls 2001;12:279-87.
4. Archer SN, Robilliard DL, Skene DJ, et al. A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. Sleep 2003;26:413-5.
5. Ebisawa T, Uchiyama M, Kajimura N, et al. Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome. EMBO Rep 2001;2:342-6.
6. Johansson C, Willeit M, Smedh C, et al. Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology 2003;28:734-9.
7. Zheng T, Holford TR, Mayne ST, et al. Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2′- bis(p-chlorophenyl) ethylene. Cancer Epidemiol Biomarkers Prev 2000;9:167-74.
8. Singletary SE, Allred C, Ashley P, et al. Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. Surg Clin North Am 2003;83:803-19.
9. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002;111:41-50.
10. Shah PN, Mhatre MC, Kothari LS. Effect of melatonin on mammary carcinogenesis in intact and pinealectomized rats in varying photoperiods. Cancer Res 1984;44:3403-7.
11. Anderson LE, Morris JE, Sasser LB, Stevens RG. Effect of constant light on DMBA mammary tumorigenesis in rats. Cancer Lett 2000;148:121-6.
12. Filipski E, King VM, Li X, et al. Host circadian clock as a control point in tumor progression. J Natl Cancer Inst 2002;94:690-7.
13. Hansen J. Increased breast cancer risk among women who work predominantly at night. Epidemiology 2001;12:74-7.
14. Davis S, Mirick DK, Stevens RG. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 2001;93:1557-62.
15. Schernhammer ES, Laden F, Speizer FE, et al. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst 2001;93:1563-8.
16. Hahn RA. Profound bilateral blindness and the incidence of breast cancer. Epidemiology 1991;2:208-10.
17. Verkasalo PK, Pukkala E, Stevens RG, Ojamo M, Rudanko SL. Inverse association between breast cancer incidence and degree of visual impairment in Finland. Br J Cancer 1999;80:1459-60.
18. Cui J, Antoniou AC, Dite GS, et al. After BRCA1 and BRCA2 - what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer. Am J Hum Genet 2001;68:420-31.
19. Takumi T, Taguchi K, Miyake S, et al. A light-independent oscillatory gene mPer3 in mouse SCN and OVLT. EMBO J 1998;17:4753-9.
20. Retsky M, Demicheli R, Hrushesky W. Premenopausal status accelerates relapse in node positive breast cancer: hypothesis links angiogenesis, screening controversy. Breast Cancer Res Treat 2001;65:217-24.
21. Demicheli R, Bonadonna G, Hrushesky WJ, Retsky MW, Valagussa P. Menopausal status dependence of early mortality reduction due to diagnosis of smaller breast cancers (T1 v T2-T3): relevance to screening. J Clin Oncol 2004;22:102-7.
22. Bluming A, Hrushesky WJ. The effect of surgical timing within the fertility cyde on breast cancer outcome. Ann N Y Acad Sci 1991:618277-91.
23. Hagen AA, Hrushesky WJ. Menstrual timing of breast cancer surgery. Am J Surg 1998;175:245-61.
24. Bove K, Lincoln DW, Wood PA, Hrushesky WJ. Fertility cycle influence on surgical breast cancer cure. Breast Cancer Res Treat 2002;75:65-72.